Rounding out a year of insider trading charges involving biopharma companies, the U.S. SEC reported Dec. 30 that it had filed a complaint against two top Humanigen Inc. executives, Cameron Durrant, ...
An artificial intelligence-based tool developed by researchers in the U.K. is helping doctors identify people at risk of developing atrial fibrillation. Data from the ongoing Find-AF pilot study shows ...
Sangamo Therapeutics Inc.’s stock sank sharply on the last day of 2025 as Pfizer Inc. handed back the rights to their collaborative gene therapy hemophilia A program. While it was another big loss to ...
Driven by declining competitiveness, the new European Commission will start 2025 by getting to work on an EU-wide industrial ...
Ausperbio Therapeutics Inc. raised $110 million from two financing rounds in 2024 to advance its lead antisense ...
From local drug discovery to global innovation, economic uncertainty is taking a toll on China’s innovative biotech system, ...
Daiichi Sankyo Co. Ltd.’s trophoblast cell surface antigen 2 (Trop2)-directed antibody-drug conjugate (ADC), datopotamab ...
Among the most profound results presented at the 2024 European Society for Medical Oncology Congress were the 10-year data ...
Novel vaccines that can effectively target both coronaviruses and influenza viruses would be desirable to counteract the ...
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of ...
Azole derivatives have been used as antifungal drugs in clinical practice for many years. However, limitations such as ...
In a deal worth up to $1 billion, Ideaya Biosciences Inc. is in-licensing Jiangsu Hengrui Pharmaceuticals Co. Ltd.’s SHR-4849 ...